
Jan 20 (Reuters) - BioXcel Therapeutics Inc BTAI.O:
BIOXCEL THERAPEUTICS SUBMITS SUPPLEMENTAL NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR IGALMI® LABEL EXPANSION IN THE AT-HOME SETTING
BIOXCEL THERAPEUTICS INC: SUBMISSION TIMELINE SUPPORTS POTENTIAL APPROVAL OF IGALMI LABEL EXPANSION AS EARLY AS YEAR-END 2026